Companies / Htg Molecular Diagnostics, Inc
Htg Molecular Diagnostics, Inc
HTGMCIK 1169987
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 11, 2015 | Glaxosmithkline PLC 10% owner | Buy Open-market buy | Common Stock | $5.11M | +365K | 365,106 | high |
| Jun 10, 2021 | Lubniewski John L CEO | Grant Grant or award | Common Stock | $3.9K | +1K +9.58% | 11,442 | low |
| Dec 10, 2021 | Godlewski Laura Lee Executive | Grant Grant or award | Common Stock | $3.6K | +1K +52.52% | 2,904 | low |
| Dec 10, 2021 | Lubniewski John L CEO | Grant Grant or award | Common Stock | $3.6K | +1K +8.84% | 12,318 | low |
| Dec 10, 2021 | Lawson Byron Executive | Grant Grant or award | Common Stock | $3.2K | +896 +27.94% | 4,103 | low |
| Jun 10, 2021 | Godlewski Laura Lee Executive | Grant Grant or award | Common Stock | $2.6K | +672 +54.55% | 1,904 | low |
| Dec 10, 2021 | McMeans Shaun D Executive | Grant Grant or award | Common Stock | $1.9K | +520 +6.39% | 8,661 | low |
| Jun 10, 2021 | McMeans Shaun D Executive | Grant Grant or award | Common Stock | $1.8K | +469 +6.06% | 8,203 | low |